Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Ceconomy AG meldet starkes Umsatz- und EBIT-Wachstum für Q4 2025 (Investing.com DE) +++ CECONOMY Aktie -3,30%

ANIKA Aktie

>ANIKA Performance
1 Woche: -1,2%
1 Monat: -6,9%
3 Monate: +10,2%
6 Monate: -16,9%
1 Jahr: -50,0%
laufendes Jahr: -48,7%
>ANIKA Aktie
Name:  ANIKA THERAPEUTICS DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US0352551081 / 889120
Symbol/ Ticker:  AKP (Frankfurt) / ANIK (NASDAQ)
Kürzel:  FRA:AKP, ETR:AKP, AKP:GR, NASDAQ:ANIK
Index:  -
Webseite:  https://www.anikatherapeu..
Profil:  Anika Therapeutics Inc. is a prominent player in t..
>Volltext..
Marktkapitalisierung:  116.57 Mio. EUR
Unternehmenswert:  88.05 Mio. EUR
Umsatz:  96.09 Mio. EUR
EBITDA:  -5.52 Mio. EUR
Nettogewinn:  -28.14 Mio. EUR
Gewinn je Aktie:  -1.94 EUR
Schulden:  20.87 Mio. EUR
Liquide Mittel:  49.39 Mio. EUR
Operativer Cashflow:  6.93 Mio. EUR
Bargeldquote:  3.04
Umsatzwachstum:  -34.8%
Gewinnwachstum:  67.86%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  ANIKA
Letzte Datenerhebung:  17.12.25
>ANIKA Kennzahlen
Aktien/ Unternehmen:
Aktien: 14.42 Mio. St.
Frei handelbar: 96.07%
Rückkaufquote: 6.57%
Mitarbeiter: 288
Umsatz/Mitarb.: 0.35 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 68.77%
Bewertung:
KGV: -
KGV lG: -
KUV: 1.23
KBV: 0.95
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: 54.74%
Gewinnmarge: -12.65%
Operative Marge: -10.99%
Managementeffizenz:
Gesamtkaprendite: -6.78%
Eigenkaprendite: -8.73%
>ANIKA Peer Group

Es sind 599 Aktien bekannt.
 
10.12.25 - 02:06
Vanishing act: The Anika Wells expenses exclusive pulled by News Corp (SMH)
 
The media company's free mass-market news site, news.com.au, snagged a red-hot story, so why did it spike it a few hours later?...
05.11.25 - 19:27
Anika outlines 12%–18% commercial channel revenue growth for 2025 while advancing Integrity and regulatory milestones (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 16:00
Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates (Zacks)
 
Anika (ANIK) delivered earnings and revenue surprises of +100.00% and +0.06%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...
05.11.25 - 15:54
Earnings Call Transkript: Anika Therapeutics überrascht in Q3 2025 mit unerwartetem Gewinn pro Aktie (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 15:48
Anika (ANIK) Q3 2025 Earnings Call Transcript (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 13:27
Anika Therapeutics Non-GAAP EPS of $0.04 beats by $0.02, revenue of $27.82M in-line (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 13:09
Anika Reports Third Quarter 2025 Financial Results (GlobeNewswire EN)
 
Commercial Channel revenue up 22% with continued strong Integrity™ Implant System and Hyalofast® growth, and double-digit International OA Pain Management growth...
23.10.25 - 22:03
Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025 (GlobeNewswire EN)
 
BEDFORD, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its third quarter 2025 financial results before the opening of the market on Wednesday, November 5, 2025, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights....
01.10.25 - 06:30
Biotech Stocks Rebound After Hours Amid Broader Sector Tailwinds (RTTNews)
 
Biotech stocks posted strong after-hours gains Tuesday, with several small-cap names rebounding despite limited news flow. Broader sentiment may have been supported by Pfizer's announcement of U.S. drug price cuts and a $70 billion investment in domestic manufacturing. Ovid Therapeutics, NeuroOne Medical, PepGen, Reviva Pharmaceuticals, and Anika Therapeutics all saw notable moves following mixed regular session action....
29.09.25 - 01:24
New Optus Outage Disrupts Emergency Calls Ahead of SingTel Visit (Bloomberg)
 
Optus suffered another outage that disrupted emergency calls, just as a delegation from parent company Singapore Telecommunications Ltd. visits Australia this week to meet Communications Minister Anika Wells over fallout from earlier disruptions....
26.09.25 - 06:12
SingTel, Optus CEOs to Meet Australia Minister Over Fatal Outage (Bloomberg)
 
The heads of Singapore Telecommunications Ltd. and its Optus division will meet with Australian Communications Minister Anika Wells next week as the phone company struggles with the fallout of a network outage that resulted in multiple deaths....
25.09.25 - 02:24
SingTel Summoned by Australia as Penalty From Fatal Outage Looms (Bloomberg)
 
Australian Communications Minister Anika Wells summoned Singapore Telecommunications Ltd. to a meeting following a fatal outage at its Optus division, warning the blunder was likely to lead to major financial penalties....
13.09.25 - 16:03
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK (PR Newswire)
 
NEW YORK, Sept. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ("Anika" or the "Company") (NASDAQ: ANIK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
08.09.25 - 21:33
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK (PR Newswire)
 
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ("Anika" or the "Company") (NASDAQ: ANIK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
08.09.25 - 11:24
BaFin warnt vor Identitätsmissbrauch zulasten der CAM Alternatives GmbH sowie der AltamarCAM Partners Gruppe in WhatsApp-Gruppen (BaFin)
 
Die Finanzaufsicht BaFin warnt vor WhatsApp-Gruppen, die angeblich von der CAM Alternatives GmbH, Köln, bzw. der AltamarCAM Partners Gruppe, Madrid, zu der die CAM Alternatives GmbH gehört, betrieben werden. Diese WhatsApp-Gruppen werden angeblich von Luis Santos sowie seinen angeblichen Assistentinnen Anika Sommer, Clara Weingart, Jana Kuhn, Helena Meyer, Franziska Brandt, Lea Koch, Laura Fischer, Seva Hartwig, Lina Sommer und Ena Sophie Wagner geleitet....
05.09.25 - 11:03
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
 
BEDFORD, Mass., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on September 2, 2025, Anika granted non-statutory stock options (“Options”) covering an aggregate of 2,500 shares of common stock at a per share exercise price of $9.15, which equaled the closing price of common stock on the Nasdaq Global Select Market on the grant date, to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with Nasdaq Listing Rule 5635(c)(4), was made as a material inducement to the grantee's acceptance of employment with Anika as a component of the grantee's employment compensation....
29.08.25 - 17:30
Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High? (Zacks)
 
The consensus price target hints at a 98.6% upside potential for Anika (ANIK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term....
27.08.25 - 16:01
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK (PR Newswire)
 
NEW YORK, Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ("Anika" or the "Company") (NASDAQ: ANIK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
20.08.25 - 19:45
Anika (ANIK) Upgraded to Buy: Here′s What You Should Know (Zacks)
 
Anika (ANIK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)....
07.08.25 - 14:15
Anika Therapeutics: Unterschätzter Orthopädie-Spezialist (Sharedeals)
 
Trotz schwacher Kursentwicklung in den vergangenen Jahren bietet Anika Therapeutics mittlerweile ein attraktives Chance-Risiko-Verhältnis für langfristige Anleger. Mit einem innovativen Produktportfolio, das auf hyaluronsäurebasierten Lösungen aufbaut, erschließt das Unternehmen milliardenschwere Märkte in der orthopädischen Schmerztherapie und Geweberegeneration. Fokus auf regenerative Medizin Anika Therapeutics, mit Sitz in Bedford, Massachusetts, wurde 1992 gegründet und ist auf die […] The post Anika Therapeutics: Unterschätzter Orthopädie-Spezialist first appeared on sharedeals.de....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der Mensch ward zum Tun und nicht zum Vernünfteln erschaffen. Aber eben deswegen, weil er nicht dazu erschaffen ward, hängt er diesem mehr als jenem nach. - Gotthold Ephraim Lessing
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!